Pfizer PFE Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pfizer's other non-current assets?
- Pfizer (PFE) reported other non-current assets of $9.83B in Q1 2026.
- How has Pfizer's other non-current assets changed year-over-year?
- Pfizer's other non-current assets decreased by 0.1% year-over-year, from $9.85B to $9.83B.
- What is the long-term trend for Pfizer's other non-current assets?
- Over 5 years (2020 to 2025), Pfizer's other non-current assets has grown at a 14.6% compound annual growth rate (CAGR), from $4.88B to $9.63B.
- What does other non-current assets mean?
- This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.